Dow futures turned higher Tuesday after Trump returned to the White House Monday evening despite only arriving at Walter Reed medical center on Friday. Most medical experts don’t see how Trump can safely go back to the White House as Covid-19 stays in our system for 14 days.

In the last episode of Mad Money, Jim Cramer said that the stock market has something for everyone as President Donald Trump was reportedly doing better, while Democratic challenger Joe Biden continues to widen his lead in the polls. That sent many different sectors rallying, even if they typically wouldn’t trade in tandem.

TheStreet’s Katherine Ross and Cramer are on Street Lightning talking about Regeneron stock after the Pharmaceuticals company new deal, the Bristol Meyers deal, and renewed hopes over the stimulus package. 

Regeneron Stock: Buy or Sell?

Regeneron Pharmaceuticals Inc.  (REGN) – Get Report shares jumped higher Monday amid speculation the drugmaker could soon receive Emergency Use Authority from the Food & Drug Administration after its coronavirus treatment was given to President Donald Trump. 

Source Article